Accès gratuit
Numéro
Med Sci (Paris)
Volume 19, Numéro 5, Mai 2003
Page(s) 519 - 521
Section Le Magazine : Nouvelles
DOI https://doi.org/10.1051/medsci/2003195519
Publié en ligne 15 mai 2003
  1. Köhler G, Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–7.
  2. Tramontano A, Janda KD, Lerner RA. Catalytic antibodies. Science 1986; 234: 1566.
  3. Pollack SJ, Jacobs JW, Schultz PG. Selective chemical catalysis by an antibody. Science 1986; 234: 1570.
  4. Wirsching P, Ashley JA, Lo CHL, et al. Reactive immunization. Science 1995; 270: 1775–8.
  5. Wentworth P, Liu YQ, Wentworth AD, et al. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis. Proc Natl Acad Sci USA 1998; 95: 5971–5.
  6. Flanagan ME, Jacobsen JR, Sweet E, Schultz PG. Antibody-catalyzed retroaldol reaction. J Am Chem Soc 1996; 118: 6078–9.
  7. Hasserodt J. Organic synthesis supported by antibody catalytis. Synlett 1999; 12: 2007–22. 522 M/S n° 5, vol. 19, mai 2003
  8. Hilvert D. Critical analysis of antibody catalysis. Annu Rev Biochem 2000; 69: 751.
  9. Jerne NK. Toward a network theory of the immune system. Ann Immunol (Paris) 1974; 125C: 373–89.
  10. Izadyar L, Friboulet A, Remy MH, et al. Monoclonal antiidiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity. Proc Natl Acad Sci USA 1993; 90: 8876–80.
  11. Avalle B, Thomas D, Friboulet A. Functional mimicry: elicitation of a monoclonal anti-idiotypic antibody hydrolizing betalactams. FASEB J 1998; 12: 1055–60.
  12. Pillet D, Paon M, Vorobiev II, et al. Idiotypic network mimicry and antibody catalysis: lessons for the elicitation of efficient anti-idiotypic protease antibodies. J Immunol Meth 2003; 269: 5–12.
  13. Friboulet A, Avalle B, Debat H, Thomas D. A possible role of catalytic antibodies in metabolism. Immunol Today 1999; 20: 474–5.
  14. Kit YY, Semenov DV, Nevinsky GA. Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin A. Biochem Mol Biol Int 1996; 39: 521–7.
  15. Kanyshkova TG, Semenov DV, Khlimankov D, et al. DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers. FEBS Lett 1997; 416: 23–6.
  16. Paul S, Volle DJ, Beach CM, et al. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 1989; 244: 1158–62.
  17. Li L, Paul S, Tyutyulkova S, et al. Catalytic activity of anti-thyroglobulin antibodies. J Immunol 1995; 154: 3328–32.
  18. Thiagarajan P, Dannenbring R, Matssura K, et al. Monoclonal antibody light chain with prothrombinase activity. Biochemistry 2000; 39: 6459–65.
  19. Lacroix-Desmazes S, Moreau A, Sooryanarayana S, et al. Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat Med 1999; 5: 1044–7.
  20. Shuster AM, Gololobov GV, Kvashuk OA, et al. DNA hydrolyzing autoantibodies. Science 1992; 256: 665–7.
  21. Vlassov A, Florentz C, Helm M, et al. Characterization and selectivity of catalytic antibodies from human serum with RNase activity. Nucleic Acids Res 1998; 26: 5243–50.
  22. Baranovskii AG, Ershova NA, Buneva VN, et al. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol Lett 2001; 76: 163–7.
  23. Lacroix-Desmazes S, Bayry J, Misra N, et al. The prevalence of proteolytic antibodies against factor VIII in hemophilia A. N Engl J Med 2002; 346: 662–7.
  24. Wentworth JP, McDunn JE, Wentworth AD, et al. Evidence of antibodycatalyzed ozone formation in bacterial killing and inflammation. Science 2002; 298: 2195–9.
  25. Wentworth A, Jones L, Wentworth P, et al. Antibodies have the intrinsic capacity to destroy antigens. Proc Natl Acad Sci USA 2000; 97: 10930–5.
  26. Nardi M, Tomlinson S, Greco MA, Karpatkin S. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1- related immune thrombocytopenia. Cell 2001; 106: 551–61.
  27. Tawfik DS, Chap R, Green BS, et al. Unexpectedly high occurence of catalytic antibodies in MLR/lpr and SLJ mice immunized with a transition-state analog: is there a linkage to autoimmunity. Proc Natl Acad Sci USA 1995; 92: 2145–9.
  28. Thomas NR. Hapten design for the generation of catalytic antibodies. Appl Biochem Biotechnol 1994; 47: 345–72.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.